The European Patent Office (EPO) updated the fees

The European Patent Office (EPO) updated the fees

The regular bi-annual revision of fees at the European Patent Office (EPO) has become due this year and resulted in an updated fee schedule effective as of April 1, 2020. In case of the majority of fees the increase is in the region of 4%. Renewal fees have been...
UNSUCCESFUL PROBATION OF THE USE OF A MARK

UNSUCCESFUL PROBATION OF THE USE OF A MARK

FACTS The applicant filed the International device mark for goods in class 30 (foodstuffs). Against the Hungarian part of the International mark Aldiva, the owner of the European mark protected also for foodstuffs in class 30, has filed opposition (Aldi was owner of...
Danubia attended to an IP round table in Germany

Danubia attended to an IP round table in Germany

At Union-IP’s Munich Round Table titled “Inventive step is not so obvious – How to deal with differences across Europe” held on 21 February 2020 in the German Patent and Trademark Office, Danubia represented itself with a delegation of 8 patent attorneys....
APPRECIATION OF LIKELIHOOD OF CONFUSION

APPRECIATION OF LIKELIHOOD OF CONFUSION

Decisions on likelihood of confusion always contain subjective elements, which is the case probably in most of the countries. FACTS Applicant filed the word combination: for registration as a mark in respect of goods in Class 17 insulating materials, etc. The owner of...

TRADEMARK APPLICATION IN BAD FAITH

The mark Jazzy Pub was registered for services in class 43. The owner of the earlier mark JAZZY which was registered 7 years earlier in classes 38,41 and used in Radio Jazzy requested cancellation of the later mark.

LES (Licensing Executives Society) Conference

LES (Licensing Executives Society) Conference

Our colleagues visited to Vienna on 21-22 November 2019 to participate in the conference „IP Concert in 2 Movements”, which was held on the occasion of the 40th anniversary of LES (Licensing Executives Society) Austria. István Molnár presented the IP Prosecution in the Pharma Industry.